Eric Fain

TL;DR: Subclinical atrial tachyarrhythmias, without clinical atrial fibrillation, occurred frequently in patients with pacemakers and were associated with a significantly increased risk of ischemic stroke or systemic embolism.

TL;DR: Prophylactic ICD therapy does not reduce overall mortality in high-risk patients who have recently had a myocardial infarction, and is associated with a reduction in the rate of death due to arrhythmia, that was offset by an increase in the rates of death from nonarrhythmic causes.

TL;DR: Despite use of advanced ICD technology and treatment with a beta-blocker, shocks occur commonly in the first year after ICD implant, and amiodarone plus beta- blocker is effective for preventing these shocks and is more effective than sotalol but has an increased risk of drug-related adverse effects.

TL;DR: Although SCAF is associated with an increased risk of stroke and embolism, very few patients had SCAF in the month before their event, and only 1 of these 4 patients was experiencing SCAF at the time of the stroke.

TL;DR: Although amiodarone increased DFT, the effect size with modern ICD systems is very small, and DFT reassessment after the institution of antiarrhythmic drug therapy with amioarone or sotalol is not routinely required.